NCT00774059 is a NA clinical trial of Breast lift system in Breast Ptosis, sponsored by Maastricht University Medical Center.

Who is sponsoring NCT00774059?

NCT00774059 is sponsored by Maastricht University Medical Center.

What drugs are being tested in NCT00774059?

Interventions in NCT00774059: Breast lift system.

What condition does NCT00774059 study?

NCT00774059 studies Breast Ptosis.

Is NCT00774059 still recruiting?

NCT00774059 is currently withdrawn. Last updated 12 October 2017.

Last reviewed 2017-10-12 · How we verify

NCT00774059

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of Safety and Performance of the Orbix Breast Lift System

Withdrawn NA Last updated 12 October 2017

What this trial tests

NA trial testing Breast lift system in Breast Ptosis. Withdrawn.

Quick facts

Lead sponsor	Maastricht University Medical Center
Phase	NA
Status	Withdrawn
Study type	INTERVENTIONAL
Design	parallel
Masking	none
Primary purpose	prevention
Sites	1 location across Netherlands

Drugs / interventions tested

Breast lift system

Conditions studied

Breast Ptosis — all drugs for Breast Ptosis →

Sponsor

Maastricht University Medical Center

Who can join

Adults 30 to 50, female only, with Breast Ptosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study is using a new breast lift system to complement a breast-lift operation. In general there will be recurrence of breast-ptosis after a correcting operation. With this device we want to minimize this recurrence and provide an "internal bra".

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Maastricht University Medical Center trials

Trials by the same sponsor.

NCT04603261 — Time to Excretion of Contrast, a Maastricht Prospective Observational Study · withdrawn
NCT04598516 — Maastricht Investigation of Renal Function in Absence of- and Post- Contrast in Patients With eGFR LEss Than 30 · withdrawn
NCT04597892 — Efficacy of Point-Of-Care Creatinine Assays in Patients With eGFR <30 Receiving Intravascular Contrast · withdrawn
NCT07287358 — Optimal Cerebral Perfusion Pressure Guided Therapy: Assessment of Target Effectiveness - II · NA · not yet recruiting
NCT07501780 — Real-world Evaluation of the Implementation of LC-OCT in Daily Clinical Practice · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00774059 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Maastricht University Medical Center
Last refreshed: 12 October 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00774059.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing